NUF Nufarm Limited

Nufarm Partners with KD Nutra on Plant-Based Omega-3 Portfolio Expansion

Nufarm Partners with KD Nutra on Plant-Based Omega-3 Portfolio Expansion

WEST SACRAMENTO, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Nuseed® Nutritional US Inc., the seed technologies platform of Nufarm Limited (ASX: NUF), is partnering with KD Nutra, a division of The KD Pharma Group, to expand offerings of plant-based long-chain omega-3 ingredients. This partnership allows both companies to leverage their expertise to offer the market new sources of omega-3 beyond marine sources and tap into the rapidly growing demand for alternatives.

Nufarm is a global leader in developing agricultural solutions to environmental challenges. Our Omega-3 Canola is the world’s first plant-based source of total omega-3 nutrition. Aquaterra® and Nutriterra® are derived from the seed oil and provide alternatives to marine-sourced omega-3 ingredients while delivering all the health benefits that come with this science-backed nutrient.

“Our combined technologies and capabilities have great potential for human health,” said Brent Zacharias, Nufarm, Group Executive for Seed Technologies. “KD Nutra’s technical expertise and commitment to quality can deliver our plant-based innovations to a broader audience.”

“We’re excited to partner with Nufarm to expand our plant-based omega-3 offerings,” said Kimberly Smith, CEO of KD Nutra. “Nufarm’s innovation in plant-based nutrition together with KD Nutra’s technology platform and leadership in omega-3 will allow us to bring unique and renewable solutions to the industry.”

This research and development partnership will increase access to omega-3 nutrition for the long-term health of people and the planet.

About Nufarm

Nufarm is a global agricultural innovator providing crop protection and seed technology solutions to help our customers grow a better tomorrow. Established over 100 years ago, Nufarm is listed on the Australian Securities Exchange (ASX:NUF) with its head office in Melbourne, Australia. Nufarm is the first company to develop and commercialise plant-based omega-3 and has developed and commercialized advanced bioenergy feedstock technology. Learn more at:

Nufarm’s seed technologies platform (Nuseed) is focused on enabling the transformation of key crops into renewable and traceable sources of lower-carbon energy, and plant-based nutrition. Its proprietary solutions contribute to solving global challenges like food security, human nutrition, and climate change. Nutriterra® is designed for human nutrition from our Omega-3 Canola, the world’s first plant-based source of long-chain omega-3 fatty acids. Nutriterra provides a sustainable land-based oil supply, helping reduce pressure on wild fish stocks and closing the gap between how much omega-3 is needed to support human health and how little the ocean can provide. Learn more at  and .

About KD Nutra®

KD Nutra® is a technology-driven CDMO with leading expertise in ultra-potent marine-based and algae-based Omega-3 nutritional lipids as well as Specialized Pro-resolving Mediators (SPMs).

As part of the KD Pharma Group, KD Nutra® has become one of the world’s largest Omega-3 and fish oil refiners and suppliers.

Our processing systems can manufacture any desired combination of concentration level (up to 99%) and EPA/DHA Omega-3 ratio. Additionally, our kd-pür® supercritical CO2 patented process gently extracts and purifies Omega-3s in a pharmaceutical cGMP-certified facility, without the use of excessive heat, chemical solvents (green technology) or oxygen. Through our unique vertical integration from raw oils to ultra-high potency Omega-3 EPA and DHA concentrates from both vegan and marine sources, we create health solutions for our customers.

Contacts:

Nuseed Nutritional: Katrina Benedicto, Communications Director

+1 (530) 490-1038,

Nuseed Global: Rhonda Macdonald, Global Lead, Communications & External Relations

+1 (403) 660-0717,

Nufarm Investor Relations: Grant Saligari, ,



EN
24/07/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nufarm Limited

Nufarm Limited: 1 director

A director at Nufarm Limited bought 75,000 shares at 3.890AUD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

 PRESS RELEASE

Nufarm Partners with KD Nutra on Plant-Based Omega-3 Portfolio Expansi...

Nufarm Partners with KD Nutra on Plant-Based Omega-3 Portfolio Expansion WEST SACRAMENTO, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Nuseed® Nutritional US Inc., the seed technologies platform of Nufarm Limited (ASX: NUF), is partnering with KD Nutra, a division of The KD Pharma Group, to expand offerings of plant-based long-chain omega-3 ingredients. This partnership allows both companies to leverage their expertise to offer the market new sources of omega-3 beyond marine sources and tap into the rapidly growing demand for alternatives. Nufarm is a global leader in developing agricul...

 PRESS RELEASE

Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Asset...

Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets WEST SACRAMENTO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company has signed a Memorandum of Understanding (“MOU”) and License Agreement with Nuseed Nutritional US Inc. (the seed technologies platform of Nufarm Limited (ASX:NUF)), granting Nufarm a commercial license to certain Omega-3 ...

Clarence Chu
  • Clarence Chu

ECM Weekly (29th May 2022)

Aequitas Research publishes weekly updates on the deals that have been covered by the team recently along with updates for upcoming IPOs in the past week.

Clarence Chu
  • Clarence Chu

Nufarm Placement

Sumitomo Chemical is looking to sell its entire stake in Nufarm Ltd to raise A$338.3m (US$240.6m). Sumitomo Chemical had been a strategic investor, where it purchased 20% of the firm via a tender offer at A$14/share. The former had also acquired Nufarm’s South American businesses in mid-2020. While this would be a clean-up sale, the deal is a large one to process at 36 days ADV.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch